NRDC v. Andrew Wheeler et al

Reference :

1:17-CV-02034-TSC

Complaint date :

October 3, 2017

Status :

Provisional judgment

Place of jurisdiction :

United States, Washignton DC

Plaintiffs types :

Environmental NGOs

Plaintiffs names :

Natural Resources Defense Council

Defendants :

EPA, Andrew Wheeler

Lawyers :

Jolie D. McLaughlin, Rebecca J. Riley, Daniel L. Raichel, Lucas J. Rhoads

Case nature :

Administrative

Specificities :

Stipulated Settlement Agreement

Products :

Imidacloprid, Dinotefuran, Acetamiprid, Neonicotinoid, Insecticide

Requests :

NRDC ask for EPA to take into account the effects of dangerous active ingredients on 95 products regarding the Endangered Species Act

Name of the Court :

United States District Court for the District of Columbia of Washignton DC, United States

Jurisdiction level :

Court

Decision date :

January 15, 2021

Decision nature :

Partially Positive

Decision content :

NRDC and EPA reached an agreement that requires EPA to begin evaluating the impacts of imidacloprid on endangered and threatened bees, butterflies, birds and other wildlife as required by the Endangered Species Act (ESA).

Legal basis :

National law

Court Ruling :

Link to the ruling

Summary :

Plaintiff files an action against EPA, alleging that it violated the Endangered Species Act (ESA), by failing to consult on the effects of 95 pesticide products registrations containing neonicotinoids: acetamiprid, dinotefuran, or imidacloprid, on Oct. 3, 2017. On Feb. 8, 2018, Parties entered into a Stipulation of Partial Dismissal of any and all claims related to 36 pesticide products. On January 15, 2021, Parties agreed to a partial settlement agreement which requires EPA to evaluate the impacts of imidacloprid and to meet to resolve the remaining issue on acetamiprid and dinotefuran.

Scientific references :

No scientifice reference for this case.